Search Results

You are looking at 41 - 50 of 152 items for :

Clear All
Full access

Ghadeer Olleik, Wassim Kassouf, Armen Aprikian, Jason Hu, Marie Vanhuyse, Fabio Cury, Stuart Peacock, Elin Bonnevier, Ebba Palenius and Alice Dragomir

Clinical Excellence, American Urological Association (AUA), and the European Association of Urology (EAU), have developed their own classification systems. The AUA and EAU agree with the D'Amico classification, whereas NCCN added a fourth group to its

Full access

Venkata K. Pokuri, Houman Nourkeyhani, Bodie Betsy, Laurie Herbst, Marcus Sikorski, Edward Spangenthal, Andrew Fabiano and Saby George

? Urology 2001 ; 58 ( 2 Suppl 1 ): 5 – 9 . 3. Huggins C Stevens RE Jr Hodges CV . Studies on prostate cancer. II. The effect of castration on advanced carcinoma of the prostate gland . Arch Surg 1941 ; 43 : 209 – 223 . 4. Tolis G

Full access

Jason Hu, Armen G. Aprikian, Marie Vanhuyse and Alice Dragomir

could potentially increase BMD testing rates. In contrast, these recommendations are mentioned in the European Association of Urology PCa-specific guidelines. 41 In the context of breast cancer, guidelines also recommend that women treated with hormone

Full access

Peter E. Clark, Philippe E. Spiess, Neeraj Agarwal, Matthew C. Biagioli, Mario A. Eisenberger, Richard E. Greenberg, Harry W. Herr, Brant A. Inman, Deborah A. Kuban, Timothy M. Kuzel, Subodh M. Lele, Jeff Michalski, Lance Pagliaro, Sumanta K. Pal, Anthony Patterson, Elizabeth R. Plimack, Kamal S. Pohar, Michael P. Porter, Jerome P. Richie, Wade J. Sexton, William U. Shipley, Eric J. Small, Donald L. Trump, Geoffrey Wile, Timothy G. Wilson, Mary Dwyer and Maria Ho

Association of Urology determined risk stratification groups for patients with nonpalpable ILNs, and validated this in both univariate and multivariate analyses of prognostic factors. Patients can be stratified according to stage and/or grade into risk groups

Full access

Peter B. Bach, Stephen B. Edge, Linda House, Jennifer Malin, James L. Mohler and Clifford Goodman

as part of the patient visit. He personally finds them helpful in discussions with his urology patients because there are many treatment options for prostate cancer, and the Guidelines spell them all out. “We use guidelines to turn things around so

Full access

Ashley E. Ross

E. Ross, MD, PhD, of The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Dr. Ross, Assistant Professor of Urology, Oncology, and Pathology, reviewed the evidence supporting the validity of currently available molecular prognostic tests

Full access

Joseph J. Fantony and Brant A. Inman

Habuchi T Grossman HB . Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers . Urology 2005 ; 66 ( 6 Suppl 1 ): 35 – 63 . 6. Yafi FA Brimo F Steinberg J . Prospective analysis of sensitivity and

Full access

Philip W. Kantoff and James L. Mohler

2013: early detection, over-treatment, active surveillance, and salvage radiation. Dr. Mohler is Associate Director for Translational Research and Chair of Urology at Roswell Park Cancer Institute. Figure 2 The prostate cancer treatment

Full access

Crystal S. Denlinger, Robert W. Carlson, Madhuri Are, K. Scott Baker, Elizabeth Davis, Stephen B. Edge, Debra L. Friedman, Mindy Goldman, Lee Jones, Allison King, Elizabeth Kvale, Terry S. Langbaum, Jennifer A. Ligibel, Mary S. McCabe, Kevin T. McVary, Michelle Melisko, Jose G. Montoya, Kathi Mooney, Mary Ann Morgan, Tracey O’Connor, Electra D. Paskett, Muhammad Raza, Karen L. Syrjala, Susan G. Urba, Mark T. Wakabayashi, Phyllis Zee, Nicole McMillian and Deborah Freedman-Cass

Kelly D . Discussing the sexual consequences of treatment in radiotherapy and urology consultations with couples affected by prostate cancer . BJU Int 2012 ; 109 : 98 – 103 . 7. White ID Allan H Faithfull S . Assessment of treatment

Full access

Peter H. Carroll and James L. Mohler

“There may be a cancer subject that is more controversial than the screening and early detection of prostate cancer, but I don't know what that is,” said Peter H. Carroll, MD, MPH, Professor and Chair, Department of Urology, UCSF Helen Diller